HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Thematic (Sector/Industry)

<ul>
<li>Although DeepSeek's continuous updates, iterations, and deep integration with more and more healthcare enterprises in China will bring positive market sentiment, we have seen certain limitations and even risks behind.</li>
<li>Currently, AI healthcare relies heavily on government subsidies or hardware sales in China, which lacks sustainable payment scenarios and profit model. The data security/privacy/compliance issue may not be completely solve.</li>
<li>For the companies that have integrated with DeepSeek, investors need to verify their afterwards financial performance and fundamentals. If it does not meet expectations, investors are recommended sell in time.</li>
</ul>


Although DeepSeek's continuous updates, iterations, and deep integration with more and more healthcare enterprises in China will bring positive market sentiment, we have seen certain limitations and even risks behind.
Currently, AI healthcare relies heavily on government subsidies or hardware sales in China, which lacks sustainable payment scenarios and profit model. The data security/privacy/compliance issue may not be completely solve.
For the companies that have integrated with DeepSeek, investors need to verify their afterwards financial performance and fundamentals. If it does not meet expectations, investors are recommended sell in time.


DeekSeek May Not Be The "Game Changer" In China Healthcare - Time to Be Rational

Equity Capital Markets

Sinohealth Technology Holdings / Equity Capital Markets

<p>Due to the COVID-19, medical technology has once again become a hot concept, and the digital era of the healthcare industry has arrived. Meanwhile, many technology companies providing healthcare big data solutions are heading to the capital markets. On June 25, 2021, <a href="https://www.smartkarma.com/entities/sinohealth-technology-holdings-limited" target="_blank" data-smartkarma-citation="entities:33564:1" rel="noopener">Sinohealth Technology Holdings (SHT HK)</a> officially kicked off the IPO process by submitting its prospectus to the HKEX. Sinohealth is a leading technology company committed to providing big data solutions to corporate clients in China’s healthcare industry driven by big data and AI technologies. This article mainly analyzed the industry characteristics, the business and the concerns of the Company.</p>

Due to the COVID-19, medical technology has once again become a hot concept, and the digital era of the healthcare industry has arrived. Meanwhile, many technology companies providing healthcare big data solutions are heading to the capital markets. On June 25, 2021, Sinohealth Technology Holdings (SHT HK) officially kicked off the IPO process by submitting its prospectus to the HKEX. Sinohealth is a leading technology company committed to providing big data solutions to corporate clients in China’s healthcare industry driven by big data and AI technologies. This article mainly analyzed the industry characteristics, the business and the concerns of the Company.

Pre-IPO Sinohealth Technology - Solid Financial Performance Cannot Cover up the Challenges Ahead

Hong Kong

Sinohealth Holdings Limited operates as a high-tech company powered by big data and AI technology. The Company provides comprehensive solutions for enterprise-level customers in the health industry and promoting the digital transformation of the industry. Sinohealth Holdings conducts businesses in Guangdong and Hong Kong.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Sinohealth Technology Holdings (2361 HK)

DeekSeek May Not Be The "Game Changer" In China Healthcare - Time to Be Rational

DeepSeek's integration with companies brings market optimism, but risks remain due to unsustainable profit model and data security...

Xinyao (Criss) Wang

Pre-IPO Sinohealth Technology - Solid Financial Performance Cannot Cover up the Challenges Ahead

This article mainly analyzed Sinohealth in terms of the industry characteristics, its business, comparison with peers (Yidu Tech, Linkdoc, etc.),...

Xinyao (Criss) Wang

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

DeekSeek May Not Be The "Game Changer" In China Healthcare - Time to Be Rational

​DeepSeek's integration with companies brings market optimism, but risks remain due to unsustainable profit model and data security...

Xinyao (Criss) Wang

Pre-IPO Sinohealth Technology - Solid Financial Performance Cannot Cover up the Challenges Ahead

This article mainly analyzed Sinohealth in terms of the industry characteristics, its business, comparison with peers (Yidu Tech, Linkdoc, etc.),...

Xinyao (Criss) Wang

DeepSeek's integration with companies brings market optimism, but risks remain due to unsustainable profit model and data security...